Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2003
04/10/2003US20030068734 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068733 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068728 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068727 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068726 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068725 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068724 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068721 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068715 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068714 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068710 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068708 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068707 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068706 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068705 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068704 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068703 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068702 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068701 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068700 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068699 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068698 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068697 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068696 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068693 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068692 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068688 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068686 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068684 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068678 WISP polypeptides and nucleic acids encoding same
04/10/2003US20030068672 Nucleotide sequences coding polypeptide for use in the treatment of psychological, respiratory, cardiovascular and pain disorders
04/10/2003US20030068660 Methods of ameliorating arthritis by modulating JNK signalsome activity
04/10/2003US20030068659 ICAM-4 materials and methods
04/10/2003US20030068652 Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searching
04/10/2003US20030068648 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068647 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of nervous system and cancer disorders
04/10/2003US20030068628 Nucleotide sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
04/10/2003US20030068623 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068382 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer
04/10/2003US20030068320 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
04/10/2003US20030068319 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-IL8 and anti-MUC18 in diverse types of tumors
04/10/2003US20030068318 Administering to a uterine serous papillary carcinoma patient a therapeutically effective dose of a HER-2/neu (human epidermal growth factor receptor-2) antibody.
04/10/2003US20030068316 An antibody that interacts preferentially with soluble, non-fibrillar oligomeric assemblies of amyloid beta derived diffusible ligands; applied for diagnosis, prevention and treatment of neurodegenerative diseases
04/10/2003US20030068314 Anti-diarrheal and method for using the same
04/10/2003US20030067478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030067396 Electronic vehicle toll collection system and method
04/10/2003DE19937429C2 Verfahren zur Herstellung von immunreaktiven F(ab)¶2¶-Fragmenten monoklonaler Antikörper in Überständen von in vitro Hybridom-Kulturen und im Ascites von Mäusen Process for the preparation of immunoreactive F (ab) ¶2¶ fragments of monoclonal antibodies in hybridoma supernatants of in vitro cultures and in ascites of mice
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462790A1 Ul16 binding protein 4
04/10/2003CA2462682A1 The use of gammaglobulin for the treatment of immune-mediated diseases
04/10/2003CA2462644A1 Human and murine cytokine polypeptides
04/10/2003CA2462427A1 Treatment of hepatitis b virus infection with human monoclonal antibodies
04/10/2003CA2462424A1 A novel g protein-coupled receptor, gave 10
04/10/2003CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections
04/10/2003CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003CA2461905A1 Combined compositions and methods for tumor vasculature coagulation and treatment
04/10/2003CA2461267A1 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
04/10/2003CA2460917A1 Human tissue factor antibodies
04/10/2003CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
04/10/2003CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003CA2460257A1 Methods for diagnosing and treating heart disease
04/10/2003CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003CA2455225A1 Novel proteins and nucleic acids encoding same
04/09/2003EP1300468A2 TRNA synthetase
04/09/2003EP1300467A1 Novel polypeptide and dna thereof
04/09/2003EP1300463A1 Isolated nucleic acid molecules encoding SSX family members and uses thereof
04/09/2003EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation
04/09/2003EP1300157A1 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
04/09/2003EP1299556A2 Host cells containing multiple integrating vectors
04/09/2003EP1299546A2 Aminoacyl trna synthetases
04/09/2003EP1299545A2 Drug metabolizing enzymes
04/09/2003EP1299544A2 Fimh adhesin proteins and methods of use
04/09/2003EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
04/09/2003EP1299538A2 Secreted proteins
04/09/2003EP1299536A1 Novel alpha-catenin expressed in heart and testis
04/09/2003EP1299528A1 Human olfactory receptors and genes encoding same
04/09/2003EP1299524A1 Human myeloma cell line
04/09/2003EP1299421A2 Antibodies to human mcp-1
04/09/2003EP1299420A2 Composition for pharmaceutical and cosmetic products
04/09/2003EP1299419A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
04/09/2003EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer
04/09/2003EP1299412A2 Protein modification and maintenance molecules
04/09/2003EP1299411A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
04/09/2003EP1299327A2 Phosphorylated polypeptides and uses related thereto
04/09/2003EP1299118A2 Production and use of derivatized homoserine lactones
04/09/2003EP1299032A1 DNA encoding human serine protease D-G
04/09/2003EP1276500A4 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2